Oxford-based OrganOx completed a £25m (approximately $33m) fundraising round to support the commercial growth of its normothermic machine perfusion organ preservation technology.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?